Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:Taisho Pharmaceutical Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1975
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Taisho Pharmaceutical Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Taisho Pharmaceutical Holdings Co Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Taisho Pharmaceutical Holdings Co Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for Taisho Pharmaceutical Holdings Co Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Taisho Pharmaceutical Holdings Co Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 32
Corporate Venturing – Deal reports 32
PARTNERSHIP 35
Partnership – Overview 35
Partnership – Deal reports 36
DIVESTMENTS 62
Divestments – Overview 62
Divestments – Deal reports 63
APPENDIX 69
Contact Us 69
About MarketLine Financial Deals Database 69
Deal Definition and Methodology 71
About MarketLine 78

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd M&A volume and value trend (2014-YTD2018)
Table 2: Taisho Pharmaceutical Holdings Co Ltd M&A activity by geography (2014-YTD2018)
Table 3: Taisho Pharmaceutical Holdings Co Ltd partnership volume and value trend (2014-YTD2018)
Table 4: Taisho Pharmaceutical Holdings Co Ltd partnership trend by key deal type (2014-YTD2018)
Table 5: Taisho Pharmaceutical Holdings Co Ltd divestments volume and value trend (2014-YTD2018)
Table 6: Taisho Pharmaceutical Holdings Co Ltd divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Taisho Pharmaceutical Holdings Co Ltd M&A volume and value trend (2014-YTD2018)
Figure 2: Taisho Pharmaceutical Holdings Co Ltd M&A activity by geography (2014-YTD2018)
Figure 3: Taisho Pharmaceutical Holdings Co Ltd partnership volume and value trend (2014-YTD2018)
Figure 4: Taisho Pharmaceutical Holdings Co Ltd partnership trend by key deal type (2014-YTD2018)
Figure 5: Taisho Pharmaceutical Holdings Co Ltd divestments volume and value trend (2014-YTD2018)
Figure 6: Taisho Pharmaceutical Holdings Co Ltd divestments by geography (2014-YTD2018)

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Delta Corporation Limited:企業の戦略・SWOT・財務情報
    Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TransCanada Corp (TRP):石油・ガス:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • Aquion Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Aquion Energy Inc (Aquion) is a diversified company. The company manufactures and markets saltwater batteries. It offers bulk energy storage modules, M-line battery modules, and S-line battery stacks. Aquion utilizes Aqueous Hybrid Ion battery technology to provide long-duration energy stora …
  • Mapfre SA (MAP):企業の財務・戦略的SWOT分析
    Mapfre SA (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Enel SpA (ENEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • ImmusanT Inc-医療機器分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Tethys Petroleum Ltd (TPL.H):企業の財務・戦略的SWOT分析
    Tethys Petroleum Ltd (TPL.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The 77 Bank Ltd:企業の戦略・SWOT・財務情報
    The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pharmaxis Ltd (PXS)-製薬・医療分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Holding Slovenske elektrarne d.o.o.:企業の戦略的SWOT分析
    Holding Slovenske elektrarne d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • KAMCO Investment Co KSCP (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Co KSCP (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Gilead Sciences Inc (GILD)-医療機器分野:企業M&A・提携分析
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus (HIV) in …
  • Malayan Banking Berhad:企業の戦略・SWOT・財務情報
    Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Regenicin Inc (RGIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • Pancake House, Inc.:企業の戦略・SWOT・財務情報
    Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Medical Developments International Ltd (MVP)-製薬・医療分野:企業M&A・提携分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company’s products include penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which inclu …
  • Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • BASF Corp:企業の戦略的SWOT分析
    BASF Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • CoLucid Pharmaceuticals Inc (CLCD)-製薬・医療分野:企業M&A・提携分析
    Summary CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucid’s lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous system and selectively targets 5-HT1F receptors expressed in the t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆